Tefron Ltd.
TFRFF
$7.34
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 20.70% | 19.64% | 19.90% | 17.76% | 9.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.70% | 19.64% | 19.90% | 17.76% | 9.52% |
| Cost of Revenue | 20.74% | 19.17% | 18.49% | 17.02% | 8.73% |
| Gross Profit | 20.56% | 21.26% | 24.97% | 20.35% | 12.27% |
| SG&A Expenses | 19.23% | 14.70% | 8.66% | 3.49% | 1.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -4.34% | -- | -- | -- | -- |
| Total Operating Expenses | 20.56% | 19.01% | 17.43% | 15.24% | 7.78% |
| Operating Income | 22.40% | 27.01% | 54.94% | 54.95% | 35.37% |
| Income Before Tax | 35.30% | 49.79% | 98.00% | 93.98% | 47.43% |
| Income Tax Expenses | 26.23% | 34.46% | 62.15% | 46.86% | 49.41% |
| Earnings from Continuing Operations | 38.22% | 55.12% | 112.44% | 117.50% | 46.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.22% | 55.12% | 112.44% | 117.50% | 46.81% |
| EBIT | 22.40% | 27.01% | 54.94% | 54.95% | 35.37% |
| EBITDA | 20.99% | 26.76% | 47.63% | 45.25% | 29.69% |
| EPS Basic | 35.43% | 54.82% | 113.19% | 121.18% | 47.43% |
| Normalized Basic EPS | 32.85% | 49.48% | 98.44% | 96.81% | 48.08% |
| EPS Diluted | 32.31% | 48.69% | 106.52% | 115.86% | 49.88% |
| Normalized Diluted EPS | 30.35% | 42.61% | 91.16% | 91.26% | 49.47% |
| Average Basic Shares Outstanding | 2.26% | -0.20% | -0.05% | -1.02% | -0.25% |
| Average Diluted Shares Outstanding | 3.41% | 5.28% | 3.24% | 1.36% | -1.30% |
| Dividend Per Share | 0.00% | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |